0001104659-18-057851.txt : 20180920
0001104659-18-057851.hdr.sgml : 20180920
20180920175942
ACCESSION NUMBER: 0001104659-18-057851
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180920
FILED AS OF DATE: 20180920
DATE AS OF CHANGE: 20180920
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kruse Bo
CENTRAL INDEX KEY: 0001752940
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 181080211
MAIL ADDRESS:
STREET 1: C/O Y-MABS THERAPEUTICS, INC.
STREET 2: 230 PARK AVENUE, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 750 THIRD AVENUE
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
3
1
a3.xml
3
X0206
3
2018-09-20
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001752940
Kruse Bo
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVE, 33RD FLOOR
NEW YORK
NY
10169
1
1
0
0
EVP, CFO, Secy & Treas.
Common Stock
300000
D
Common Stock
57077
I
By Investeringsselskabet G.H. ApS
Employee Stock Option (right to buy)
2.00
2025-06-10
Common Stock
300000
D
Employee Stock Option (right to buy)
4.38
2026-10-21
Common Stock
133000
D
Employee Stock Option (right to buy)
8.50
2026-12-14
Common Stock
14000
D
Employee Stock Option (right to buy)
11.16
2028-04-24
Common Stock
75000
D
Investeringsselskabet G.H. ApS is Reporting Person's personal holding company of which Reporting Person is the sole owner and as such has the sole voting and dispositive power with respect to such shares.
The stock option vested and became exercisable as to 25% of the shares subject to the option on June 10, 2016, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
The stock option vested and became exercisable as to 25% of the shares subject to the option on October 21, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
The stock option vested and became exercisable as to 25% of the shares subject to the option on December 14, 2017, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
The stock option shall vest and become exercisable as to 25% of the shares subject to the option on April 24, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
/s/ Bo Kruse
2018-09-20